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3D cell culture is a process used to grow cells in vitro to mimic an in vivo
environment. 3D cell models are very useful for understanding disease mechanisms
and exploring drug therapeutics. 3D cultures can be grown from cells taken from
cancer organoids in patients. Once grown, they can be used to screen for small
molecule drugs or they can be genetically modified in order to analyse disease
pathways or predict the toxicity or efficacy of a drug treatment. These cultures
decrease the need to use animals in research and provides more reliable results as it
uses human physiology.
This protocol describes the in vitro generation of spheroids using the low attachment
plate method. This method uses low-adhesion plates that are coated with hydrophilic
polymer to allow cells to cluster together, forming their own extracellular matrix,
rather than sticking to the plate surface. The scaffold-free 3D cell culture models
produced can more accurately reflect an in vivo microenvironment making them
useful in the study of oncology, hepatotoxicity, neurology, nephrology and stem cell
biology.
A
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Figure 1: U-251 MG Human glioblastoma astrocytoma spheroids development
using low attachment plate method (initial seeding density -10000 cells/ml). A)
Tumorspheres growth after 2 days of incbubation.

B
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Figure 2: U-251 MG Human glioblastoma astrocytoma spheroids development
using low attachment plate method (initial seeding density -10000 cells/ml). B)
Tumorspheres growth after 4 days of incubation

We used low attachment plates for tumorsphere construction and plates from
Thermo Fisher Scientific and adapted protocols published by:
1. Perkinelmer.com. 2021. [online] Available at: <https://www.perkinelmer.com/labsolutions/resources/docs/gde_3d_culture_user_guide.pdf> [Accessed 18 February
2021].
2. Thermofisher.com. 2021. HepG2 Cell Line Spheroid Generation and
Characterization for HT Assays | Thermo Fisher Scientific - UK. [online] Available at:
<https://www.thermofisher.com/ie/en/home/references/protocols/cell-culture/3-dcell-culture-protocol/hepg2-cell-line-spheroid-generation.html> [Accessed 18
February 2021].
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Figure 3: Graphic representation of using low attachment plate technique

GUIDELINES
This protocol is optimized for U251MG tumorsphere formation and this same
protocol can be used for all different panel of cell lines with minor changes.
Some cell lines may require 15 minutes of incubation post-seeding and/or a pulse
spin with different rotation speed and time in a centrifuge to allow cells to
congregate more quickly before incubation.
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MATERIALS TEXT
Nunclon™ Sphera™ 96-Well (Thermo Fisher Scientific)
Complete medium (Dulbecco's Modified Eagle Medium + 10% V/V Fetal
Bovine Serum + 1% vol. of 100mM Penicillin-Streptomycin) [Sigma Aldrich]
Mammalian cells (U-251 MG Human glioblastoma astrocytoma cells)
Trypsin-EDTA solution(Sigma Aldrich)
Centrifuge with swinging bucket rotor and well-plate holder
Cell counter or cytometer
Centrifuge tubes
Sterile reagent resevoirs
Humidified incubator
Bright-field microscope
Phosphate Buffered Saline (PBS) 1X (pH41.7.4) [Sigma Aldrich]
Trypan blue stain 0.4% (Thermo Fisher Scientific)
Multi-channel micropipette and tips
100-1000 µl micropipette and tips
Cell culture flasks and dishes
Serological pipettes
SAFETY WARNINGS
Laboratory coat and gloves must be worn at all times

1

Prepare U-251MG single cell suspension at the desired seeding concentration. Cells can be from
freshly prepared culture or from frozen vials in liquid nitrogen. Frozen vials can be immediately
thawed using 37°C waterbath and maintained in Nunclon Delta T25 cell culture flask with
complete medium (Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% V/V
Fetal Bovine Serum (FBS) + 1% vol. of 100mM Penicillin-Streptomycin for 1 passage before
seeding for spheroid generation.

2

Once flasks are 70-80% confluent, medium from the flask is aspirated and U-251 MG tumor cell
monolayers are washed with 1X phosphate buffered saline (PBS; 5 ml for a 25 cm2 or 8 - 10 ml for
a 75 cm2 flask), add 0.25 X Trypsin-EDTA cell dissociation enzyme (2 ml for a 25 cm2 or 4 ml for a
75 cm2 flask) and incubate cells at 37 °C for 2 - 5 min.

3

Check cell detachment under a microscope and neutralize cell dissociation enzyme with
complete growth medium.The 0.25 X Trypsin-EDTA reagent is neutralized using 4 volumes of
complete medium

4

Centrifuge U-251 MG single cell suspension at 5000rpm for 5 min, remove supernatant, tap the
tube and re-suspend cell pellet in complete growth medium using a pipette. This should yield a
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single cell suspension without cell clusters.

5

Cells with a viability >90% can be used for spheroid generation. Mix 10µl of cells with 10µl of
Trypan Blue and count cells using a haemocytometer.

6

Calculated cell seeding density. Prepare a suitable volume of each cell seeding density to
dispense the correct volume per well multiplied by the number of wells at each cell concentration.

7

Transfer the cell suspension to a sterile reservoir and dispense 200 μl/well into ultra-low
attachment 96-well plates usinga multichannel pipette ensuring pipette tips do not touch the
surface of the wells to protect surface coating

8

Centrifuge the Nunclon™ Sphera™ 96-Well plates at 1250rpm for 5 minutes and transfer the plates
to an incubator (37 °C, 5% CO2, 95% humidity).

9

After 24h incubation, the media must be replenished. Remove 100μl media without disrupting
tumorspheres and add 100μl of fresh media (DMEM + 10%FBS + 1%Ab) into each well and
incubate at 37°C (5% CO2, 95% humidity). The sides of wells should be used to remove or add
media and pipetting should be carried out at average or below average speeds to avoid disruption
to spheroids

10

U-251 MG Human glioblastoma astrocytoma spheroids will usually form in 3-7 days from the
starting date depending on seeding density and visually confirm tumor spheroid formation daily
using Bright-field microscope.

11

Imaging and quantification of spheroids can be also be monitored in situ using a cytometer and
fluorescent live cell stains
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